The roles of cells and cytokines in the pathogenesis of psoriasis
- 21 March 2012
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 51 (4), 389-398
- https://doi.org/10.1111/j.1365-4632.2011.05154.x
Abstract
Psoriasis is considered an immune chronic disease in which T cells are accepted as important. Nowadays, it is believed that psoriasis is most likely a T helper (Th)1/Th17 induced inflammatory disease. However, some other cells, such as endothelial cells, dendritic cells, monocytic cells, neutrophils, keratinocytes, and several cytokines, appear to have, at different stages of the disease, an important role in its pathogenesis. For instance, the response to psoriasis therapy is dependent not only on the inactivation of Th1 and Th17 immune responses but also on the inactivation of dendritic cell products. Moreover, interleukin (IL)‐23 deregulation appears to be an independent factor in the pathogenesis of psoriasis. Indeed, currently, the IL‐23/Th17 axis is believed to be crucial in psoriasis pathogenesis, and its inhibition appears to be important for therapeutic achievement. This review presents the roles and interactions of cells and cytokines that are related to psoriasis pathogenesis.Keywords
This publication has 60 references indexed in Scilit:
- Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-alpha levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapyBritish Journal of Dermatology, 2010
- Cutting Edge: A Critical Functional Role for IL-23 in PsoriasisThe Journal of Immunology, 2010
- Structural Basis for the Dual Recognition of IL-12 and IL-23 by UstekinumabJournal of Molecular Biology, 2010
- Role of CD4+CD25high+FOXP3+Regulatory T Cells in PsoriasisAnnals of Dermatology, 2010
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and PsoriasisJournal of Investigative Dermatology, 2008
- Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasisHuman Genetics, 2007
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisThe Journal of Experimental Medicine, 2006
- Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammationJCI Insight, 2006
- Role of neutrophils in induction of acute inflammation in T‐cell‐mediated immune dermatosis, psoriasis: A neutrophil‐associated inflammation‐boosting loopExperimental Dermatology, 2000